[HTML][HTML] Design and validation of specific inhibitors of 17β-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in …
Advanced medullary thyroid cancers (MTCs) are now being treated with drugs that inhibit
receptor tyrosine kinases, many of which involved in angiogenesis. Response rates vary …
receptor tyrosine kinases, many of which involved in angiogenesis. Response rates vary …
Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis.
JM Day, HJ Tutill, A Purohit, MJ Reed - Endocrine-related Cancer, 2008 - europepmc.org
17beta-Hydroxysteroid dehydrogenases (17beta-HSDs) are enzymes that are responsible
for reduction or oxidation of hormones, fatty acids and bile acids in vivo, regulating the …
for reduction or oxidation of hormones, fatty acids and bile acids in vivo, regulating the …
[PDF][PDF] Design and validation of specific inhibitors of 17b-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in …
JM Day, HJ Tutill, A Purohit, MJ Reed - Endocrine-Related Cancer, 2008 - Citeseer
Abstract 17b-Hydroxysteroid dehydrogenases (17b-HSDs) are enzymes that are
responsible for reduction or oxidation of hormones, fatty acids and bile acids in vivo …
responsible for reduction or oxidation of hormones, fatty acids and bile acids in vivo …
Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis
JM Day, HJ Tutill, A Purohit, MJ Reed - Endocrine-Related Cancer, 2008 - hero.epa.gov
Abstract 17beta-Hydroxysteroid dehydrogenases (17beta-HSDs) are enzymes that are
responsible for reduction or oxidation of hormones, fatty acids and bile acids in vivo …
responsible for reduction or oxidation of hormones, fatty acids and bile acids in vivo …
Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis
JM Day, HJ Tutill, A Purohit… - Endocrine-related …, 2008 - pubmed.ncbi.nlm.nih.gov
17beta-Hydroxysteroid dehydrogenases (17beta-HSDs) are enzymes that are responsible
for reduction or oxidation of hormones, fatty acids and bile acids in vivo, regulating the …
for reduction or oxidation of hormones, fatty acids and bile acids in vivo, regulating the …
[PDF][PDF] Design and validation of specific inhibitors of 17b-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in …
JM Day, HJ Tutill, A Purohit… - Endocrine-Related Cancer, 2008 - researchgate.net
Abstract 17b-Hydroxysteroid dehydrogenases (17b-HSDs) are enzymes that are
responsible for reduction or oxidation of hormones, fatty acids and bile acids in vivo …
responsible for reduction or oxidation of hormones, fatty acids and bile acids in vivo …
[引用][C] Design and validation of specific inhibitors of 17-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis
JM Day, HJ Tutill, A Purohit, MJ Reed - Endocrine Related Cancer, 2008 - cir.nii.ac.jp
Design and validation of specific inhibitors of 17 -hydroxysteroid dehydrogenases for
therapeutic application in breast and prostate cancer, and in endometriosis | CiNii Research …
therapeutic application in breast and prostate cancer, and in endometriosis | CiNii Research …
[PDF][PDF] Design and validation of specific inhibitors of 17b-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in …
JM Day, HJ Tutill, A Purohit… - Endocrine-Related …, 2008 - scholar.archive.org
Abstract 17b-Hydroxysteroid dehydrogenases (17b-HSDs) are enzymes that are
responsible for reduction or oxidation of hormones, fatty acids and bile acids in vivo …
responsible for reduction or oxidation of hormones, fatty acids and bile acids in vivo …
[PDF][PDF] Design and validation of specific inhibitors of 17b-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in …
JM Day, HJ Tutill, A Purohit… - Endocrine-Related Cancer, 2008 - researchgate.net
Abstract 17b-Hydroxysteroid dehydrogenases (17b-HSDs) are enzymes that are
responsible for reduction or oxidation of hormones, fatty acids and bile acids in vivo …
responsible for reduction or oxidation of hormones, fatty acids and bile acids in vivo …